Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News ANI Pharmaceuticals Inc ANIP

Healthcare
ANI Pharmaceuticals, Inc. is a diversified biopharmaceutical company, which serves patients in need by developing, manufacturing and marketing branded and generic prescription pharmaceutical products, including for diseases with high unmet medical need. The Company is focused on delivering sustainable growth by scaling up its Rare Disease business through its lead asset, Purified Cortrophin Gel... see more

Recent & Breaking News (NDAQ:ANIP)

ANI Pharmaceuticals Presents at 26th Annual ROTH Conference

PR Newswire March 10, 2014

ANI Pharmaceuticals Announces Closing Of Public Offering Of Common Stock

PR Newswire March 10, 2014

ANI Pharmaceuticals Expands Generic Drug Development Agreement with Sterling Pharmaceuticals

PR Newswire March 10, 2014

ANI Pharmaceuticals to Present at 26th Annual ROTH Conference

PR Newswire March 6, 2014

ANI Pharmaceuticals Announces Pricing Of Public Offering Of Common Stock

PR Newswire March 5, 2014

ANI Pharmaceuticals Announces Proposed Public Offering Of Common Stock

PR Newswire March 4, 2014

ANI Pharmaceuticals Reports Record Net Revenues of $10.5 million, EPS from continuing operations of $0.35, and Adjusted Non-GAAP EBITDA of $3.9 Million for the Fourth Quarter Ended December 31, 2013

PR Newswire February 18, 2014

ANI Pharmaceuticals Schedules Conference Call for Fourth Quarter and Full Year 2013 Financial Results

PR Newswire February 6, 2014

RDInvesting Provides Investors with Free In-Depth Equity Reports on ANIP, CERN, CVS and ISIS

Accesswire January 24, 2014

ANI Pharmaceuticals Enters Development Agreement for Generic Drug Product with Sterling Pharmaceutical Services

PR Newswire January 6, 2014

ANI Pharmaceuticals Acquires 31 Generic Drug Products from Teva Pharmaceuticals

PR Newswire December 26, 2013

ANI Pharmaceuticals Presents At Oppenheimer 24th Annual Healthcare Conference

PR Newswire December 10, 2013

ANI Pharmaceuticals To Present At Oppenheimer 24th Annual Healthcare Conference On December 10, 2013

PR Newswire November 15, 2013

ANI Pharmaceuticals Reports Net Revenues of $7.8 million, adjusted Non-GAAP EBITDA of $1.7 Million, and EPS of $0.13 for the Third Quarter Ended September 30, 2013

PR Newswire November 7, 2013

ANI Pharmaceuticals, Inc. Announces Date for Third Quarter 2013 Earnings Release

PR Newswire October 29, 2013

ANI Pharmaceuticals Reports Net Revenues of $6.2 million and adjusted non-GAAP EBITDA of $1.2 Million for the Second Quarter Ended June 30, 2013

PR Newswire August 9, 2013